|
Name |
Integracide H
|
Molecular Formula | C36H54O7 | |
IUPAC Name* |
[(2R,3R,5R,10S,11R,12R,13R,17R)-3,12-diacetyloxy-11-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-2-yl] acetate
|
|
SMILES |
C[C@H](CCC(=C)C(C)C)[C@H]1CC=C2[C@@]1([C@H]([C@@H](C3=C2CC[C@@H]4[C@@]3(C[C@H]([C@@H](C4(C)C)OC(=O)C)OC(=O)C)C)O)OC(=O)C)C
|
|
InChI |
InChI=1S/C36H54O7/c1-19(2)20(3)12-13-21(4)26-15-16-27-25-14-17-29-34(8,9)32(42-23(6)38)28(41-22(5)37)18-35(29,10)30(25)31(40)33(36(26,27)11)43-24(7)39/h16,19,21,26,28-29,31-33,40H,3,12-15,17-18H2,1-2,4-11H3/t21-,26-,28-,29+,31-,32+,33+,35+,36-/m1/s1
|
|
InChIKey |
OSBLHZRBOYLWMH-CVJBMISOSA-N
|
|
Synonyms |
Integracide H; CHEMBL4438680
|
|
CAS | NA | |
PubChem CID | 134692982 | |
ChEMBL ID | CHEMBL4438680 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 598.8 | ALogp: | 6.8 |
HBD: | 1 | HBA: | 7 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 99.1 | Aromatic Rings: | 4 |
Heavy Atoms: | 43 | QED Weighted: | 0.186 |
Caco-2 Permeability: | -5.058 | MDCK Permeability: | 0.00001850 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.064 |
30% Bioavailability (F30%): | 0.878 |
Blood-Brain-Barrier Penetration (BBB): | 0.004 | Plasma Protein Binding (PPB): | 92.17% |
Volume Distribution (VD): | 1.905 | Fu: | 3.63% |
CYP1A2-inhibitor: | 0.028 | CYP1A2-substrate: | 0.044 |
CYP2C19-inhibitor: | 0.051 | CYP2C19-substrate: | 0.673 |
CYP2C9-inhibitor: | 0.234 | CYP2C9-substrate: | 0.197 |
CYP2D6-inhibitor: | 0.835 | CYP2D6-substrate: | 0.082 |
CYP3A4-inhibitor: | 0.664 | CYP3A4-substrate: | 0.725 |
Clearance (CL): | 2.616 | Half-life (T1/2): | 0.42 |
hERG Blockers: | 0.077 | Human Hepatotoxicity (H-HT): | 0.787 |
Drug-inuced Liver Injury (DILI): | 0.849 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.055 | Maximum Recommended Daily Dose: | 0.856 |
Skin Sensitization: | 0.733 | Carcinogencity: | 0.013 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.807 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003755 | 0.833 | D0H2MO | 0.282 | ||||
ENC003486 | 0.710 | D0X7XG | 0.275 | ||||
ENC001119 | 0.710 | D0L2UN | 0.248 | ||||
ENC003487 | 0.664 | D08BDT | 0.247 | ||||
ENC002075 | 0.370 | D0G7KJ | 0.240 | ||||
ENC005397 | 0.340 | D0Y7LD | 0.239 | ||||
ENC005630 | 0.338 | D0O5WP | 0.237 | ||||
ENC005487 | 0.337 | D02HSB | 0.237 | ||||
ENC002467 | 0.335 | D01ZOG | 0.234 | ||||
ENC003484 | 0.329 | D0C4RB | 0.234 |